Overview

Metformin in Non-Alcoholic Fatty Liver Disease

Status:
Unknown status
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The study evaluates the use of the antidiabetic medicine metformin in nonalcoholic fatty liver disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University Hospital, Aker
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Metformin